Literature DB >> 34983698

Musculoskeletal ultrasound as a screening-tool for rheumatoid arthritis: results of the "Rheuma-Truck" screening and awareness initiative.

Alexander Lautwein1, Benedikt Ostendorf1, Stefan Vordenbäumen1, Aiko Liedmann1, Ralph Brinks1, Mario Giulini1, Sarah Ohrndorf2, Marina Backhaus3, Hasan Acar1, Oliver Sander1, Jutta G Richter1, Matthias Schneider1, Philipp Sewerin4.   

Abstract

OBJECTIVE: To evaluate musculoskeletal ultrasound (MSUS) as a screening tool for rheumatoid arthritis (RA) and osteoarthritis (OA) patients in a rheumatology-screening program. PATIENTS AND METHODS: To raise awareness for rheumatic diseases, a mobile rheumatology office was deployed in different cities of Germany ("Rheuma-Truck"). Standardized questionnaire assessment, testing for rheumatoid factor and citrullinated peptide antibodies and medical student driven MSUS of the clinically dominant hand/foot including wrist, MCP-II, -III, -V, PIP-II, -III, MTP-II and -V were offered free of charge to the population. In case of suspicious results, a rheumatologist was consulted.
RESULTS: In MSUS, 192 of 560 selected volunteers (aged 18-89, mean 52.7 years; 72.9% female) had suspicious findings including synovitis or erosions primarily affecting the MTP-II (11.8%), dorsal wrist (8.9%), and MCP-II (7%). 354 of the 560 volunteers further visited a rheumatologist of whom 76 were diagnosed with RA. According to the 'US7 Score', a sum scores ≥ 5 was significantly predictive for RA (odds ratio (OR) 5.06; confidence interval (CI) 0.83-35.32). 313 volunteers displayed signs of OA including osteophytes, while MCP-II (36.2%), MCP-III (14.8%), and the wrist (10.5%) were mostly affected. Diagnosis of RA was favoured over OA if the wrist (OR 4.2; CI 1.28-13.95), MTP-II (OR 1.62; CI 1.0-2.6), and MCP-V (OR 2.0; CI 1.0-3.8) were involved.
CONCLUSION: Medical student driven MSUS by the 'US7 Score' can facilitate diagnosis of RA in rheumatology-screening programs due to the level of the score and the affected joints. A high rate of unknown OA signs was detected by MSUS. A mobile rheumatology office displays an opportunity to screen patients for RA and OA.
© 2021. The Author(s).

Entities:  

Keywords:  Musculoskeletal ultrasound; Osteoarthritis; Rheumatoid arthritis; Screening

Mesh:

Year:  2022        PMID: 34983698     DOI: 10.1186/s42358-021-00233-0

Source DB:  PubMed          Journal:  Adv Rheumatol        ISSN: 2523-3106


  24 in total

Review 1.  Recommendations for the use of ultrasound in rheumatoid arthritis: literature review and SONAR score experience.

Authors:  Pascal Zufferey; Giorgio Tamborrini; Cem Gabay; Andreas Krebs; Diego Kyburz; Beat Michel; Urs Moser; Peter M Villiger; Alexander So; Hans Rudolf Ziswiler
Journal:  Swiss Med Wkly       Date:  2013-12-20       Impact factor: 2.193

2.  A systematic literature review analysis of ultrasound joint count and scoring systems to assess synovitis in rheumatoid arthritis according to the OMERACT filter.

Authors:  Peter Mandl; Esperanza Naredo; Richard J Wakefield; Philip G Conaghan; Maria Antonietta D'Agostino
Journal:  J Rheumatol       Date:  2011-09       Impact factor: 4.666

Review 3.  A systematic literature review of US definitions, scoring systems and validity according to the OMERACT filter for tendon lesion in RA and other inflammatory joint diseases.

Authors:  María Alcalde; Maria Antonietta D'Agostino; George A W Bruyn; Ingrid Möller; Annamaria Iagnocco; Richard J Wakefield; Esperanza Naredo
Journal:  Rheumatology (Oxford)       Date:  2012-02-29       Impact factor: 7.580

Review 4.  Epidemiology of rheumatoid arthritis: determinants of onset, persistence and outcome.

Authors:  Deborah P M Symmons
Journal:  Best Pract Res Clin Rheumatol       Date:  2002-12       Impact factor: 4.098

5.  Treat-to-target biologic therapy in patients with rheumatoid arthritis is more efficacious and safe compared to delayed initiation of biologics: a real-world study.

Authors:  Christos E Lampropoulos; Philippos Orfanos; Menelaos N Manoussakis; Athanasios G Tzioufas; Haralampos M Moutsopoulos; Panayiotis G Vlachoyiannopoulos
Journal:  Clin Exp Rheumatol       Date:  2017-01-16       Impact factor: 4.473

6.  [Health services research in rheumatology : Identifying gaps in health care and filling them through innovative concepts].

Authors:  A Zink; R E Schmidt; E Edelmann
Journal:  Z Rheumatol       Date:  2019-10       Impact factor: 1.372

7.  Diagnostic value of high-frequency ultrasound and magnetic resonance imaging in early rheumatoid arthritis.

Authors:  Ming-Yu Wang; Xian-Bin Wang; Xue-Hui Sun; Feng-Li Liu; Sheng-Chuan Huang
Journal:  Exp Ther Med       Date:  2016-09-13       Impact factor: 2.447

Review 8.  Early arthritis and rheumatoid arthritis in Germany.

Authors:  H Zeidler; S Merkesdal; J L Hülsemann
Journal:  Clin Exp Rheumatol       Date:  2003 Sep-Oct       Impact factor: 4.473

Review 9.  EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update.

Authors:  Josef S Smolen; Robert Landewé; Johannes Bijlsma; Gerd Burmester; Katerina Chatzidionysiou; Maxime Dougados; Jackie Nam; Sofia Ramiro; Marieke Voshaar; Ronald van Vollenhoven; Daniel Aletaha; Martin Aringer; Maarten Boers; Chris D Buckley; Frank Buttgereit; Vivian Bykerk; Mario Cardiel; Bernard Combe; Maurizio Cutolo; Yvonne van Eijk-Hustings; Paul Emery; Axel Finckh; Cem Gabay; Juan Gomez-Reino; Laure Gossec; Jacques-Eric Gottenberg; Johanna M W Hazes; Tom Huizinga; Meghna Jani; Dmitry Karateev; Marios Kouloumas; Tore Kvien; Zhanguo Li; Xavier Mariette; Iain McInnes; Eduardo Mysler; Peter Nash; Karel Pavelka; Gyula Poór; Christophe Richez; Piet van Riel; Andrea Rubbert-Roth; Kenneth Saag; Jose da Silva; Tanja Stamm; Tsutomu Takeuchi; René Westhovens; Maarten de Wit; Désirée van der Heijde
Journal:  Ann Rheum Dis       Date:  2017-03-06       Impact factor: 19.103

10.  The US7 score is sensitive to change in a large cohort of patients with rheumatoid arthritis over 12 months of therapy.

Authors:  Tina M Backhaus; Sarah Ohrndorf; Herbert Kellner; Johannes Strunk; Wolfgang Hartung; Horst Sattler; Christof Iking-Konert; Gerd R Burmester; Wolfgang A Schmidt; Marina Backhaus
Journal:  Ann Rheum Dis       Date:  2012-09-06       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.